var data={"title":"Microbiology, epidemiology, and pathogenesis of Brucella","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Microbiology, epidemiology, and pathogenesis of Brucella</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/contributors\" class=\"contributor contributor_credentials\">Mile Bosilkovski, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/contributors\" class=\"contributor contributor_credentials\">Stephen B Calderwood, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/contributors\" class=\"contributor contributor_credentials\">Morven S Edwards, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/contributors\" class=\"contributor contributor_credentials\">Elinor L Baron, MD, DTMH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Nov 28, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Brucellosis is a zoonotic infection transmitted to humans by contact with fluids from infected animals (sheep, cattle, goats, pigs, or other animals) or derived food products such as unpasteurized milk and cheese. It is one of the most widespread zoonoses worldwide [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/1\" class=\"abstract_t\">1</a>]. Brucellosis has high morbidity both for humans and animals; it is an important cause of economic loss and public health problems in many developing countries [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/2\" class=\"abstract_t\">2</a>]. The prevalence of brucellosis has been increasing due to growing international tourism and migration [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/3,4\" class=\"abstract_t\">3,4</a>].</p><p>The microbiology, epidemiology, and pathogenesis of <em>Brucella</em> spp will be reviewed here. The clinical manifestations, diagnosis, and treatment of brucellosis are discussed separately. (See <a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-treatment-of-brucellosis\" class=\"medical medical_review\">&quot;Clinical manifestations, diagnosis, and treatment of brucellosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2037820\"><span class=\"h1\">TAXONOMY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Several species are recognized within the genus <em>Brucella</em> based on phenotypic characteristics, antigenic variation, and prevalence of infection in different animal hosts [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/5,6\" class=\"abstract_t\">5,6</a>]. <em>B. melitensis</em> (small ruminants), <em>B. abortus</em> (cattle), <em>B. suis</em> (swine), and <em>B. canis</em> (dogs) are known to cause human disease. <em>B. neotomae</em> (desert wood rats) and <em>B. ovis</em> (sheep) are not pathogenic to humans. The majority of human cases worldwide are attributed to <em>B. melitensis</em> [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/7\" class=\"abstract_t\">7</a>]. In general, <em>B. melitensis</em> and <em>B. suis</em> are more virulent for humans than <em>B. abortus</em> or <em>B. canis</em> [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/8\" class=\"abstract_t\">8</a>]. <em>B. melitensis</em>, <em>B. abortus</em>, and <em>B. suis</em> have three, seven, and five biotypes, respectively [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/5,9\" class=\"abstract_t\">5,9</a>].</p><p>Two additional <em>Brucella</em> species, <em>B. pinipedialis</em> and <em>B. ceti</em>, have been isolated from marine mammals and detected as sporadic human pathogens [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/10-12\" class=\"abstract_t\">10-12</a>]. <em>B. pinipedialis</em> and <em>B. ceti </em>differ phenotypically from the other species by their pattern of metabolic activity [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/13\" class=\"abstract_t\">13</a>]. Other relatively new species include <em>B. microti</em> (isolated from wildlife animals), <em>B. papionis</em> (isolated from baboons), and <em>B. inopinata</em> (isolated from a human breast implant wound) [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/14-16\" class=\"abstract_t\">14-16</a>].</p><p>The genome of most <em>Brucella</em> species consists of two circular chromosomes [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/9\" class=\"abstract_t\">9</a>]. Natural plasmids have not been detected [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/17\" class=\"abstract_t\">17</a>]. Sequencing and annotation of the genomes of <em>B. suis</em>, <em>B. melitensis</em>, and <em>B. abortus</em> has been completed; the majority of the open reading frames share greater than 99 percent sequence identity between species [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/18-20\" class=\"abstract_t\">18-20</a>].</p><p>The taxonomy of the genus <em>Brucella</em> is confounded by a dichotomy between the traditional (phenotypically and host preference based) and molecular species definitions [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/9,21\" class=\"abstract_t\">9,21</a>]. DNA relatedness indicates that the six classical species together with the marine mammal-derived strains represent a single genomic species [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/22-24\" class=\"abstract_t\">22-24</a>]. However, some argue that the concept of genomic species is not scientifically valid in all bacterial groups [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/25\" class=\"abstract_t\">25</a>], and differences at the genetic level support the validity of the classical species [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/26,27\" class=\"abstract_t\">26,27</a>]. The International Committee on Systematic Bacteriology subcommittee on the taxonomy of <em>Brucella</em> retains the traditional taxonomy [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/9\" class=\"abstract_t\">9</a>].</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">MICROBIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Brucellae are small, nonmotile, facultative intracellular aerobic rods, 0.5 to 0.7 micron in diameter and 0.6 to 1.5 micron in length [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/21,28\" class=\"abstract_t\">21,28</a>]. Gram staining demonstrates single tiny, gram-negative coccobacilli. With the exception of <em>Francisella tularensis</em>, <em>Brucella </em>is the smallest gram-negative organism likely to be seen in the clinical laboratory [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/9\" class=\"abstract_t\">9</a>]. <em>Brucella</em> lacks capsules, spores, and flagella [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/29\" class=\"abstract_t\">29</a>].</p><p>Most strains require complex media for growth, which may be improved by adding serum or blood [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/9\" class=\"abstract_t\">9</a>]. The optimum growth temperature is 35 to 37&deg;C. Some biovars of <em>B. abortus</em> and <em>B. suis </em>require supplementary carbon dioxide [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/29\" class=\"abstract_t\">29</a>]. Bacterial growth is slow. The classic biphasic (solid and liquid) blood culture technique of Ruiz-Castaneda is still used in developing settings, but automated blood culture systems are more effective [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/7\" class=\"abstract_t\">7</a>]. Colonies are usually 0.5 to 1.0 mm in diameter, raised and convex, with an entire edge and a smooth, shiny surface [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/9\" class=\"abstract_t\">9</a>].</p><p><em>Brucella </em>organisms can survive up to two days in milk at 8&deg;C, up to three weeks in frozen meat, and up to three months in goat cheese. Brucellae shed in animal excretions may remain viable for &gt;40 days if the soil is damp. The organisms are sensitive to heat, ionizing radiation, most commonly used disinfectants, and pasteurization [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/29-31\" class=\"abstract_t\">29-31</a>].</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Human brucellosis due to <em>B. melitensis</em> infection is the most common zoonosis worldwide [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/4\" class=\"abstract_t\">4</a>]. This infection appears to be reemerging; it is estimated that the number of <em>Brucella</em>-infected individuals may be up to 26 times higher than the 500,000 cases reported annually [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/1\" class=\"abstract_t\">1</a>].</p><p>Major endemic areas include countries of the Mediterranean basin, Persian Gulf, the Indian subcontinent, and parts of Mexico and Central and South America [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/32\" class=\"abstract_t\">32</a>]. New foci that have emerged include the Balkan Peninsula and many of the former Soviet Union Asian Republics, such as Kazakhstan, Kyrgyzstan, and Tajikistan [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/32\" class=\"abstract_t\">32</a>].</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Animal infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Brucellosis is almost invariably transmitted to humans from infected domestic animals and their contaminated products [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/33\" class=\"abstract_t\">33</a>]. Abortion or premature births are characteristic (but not specific) signs of brucellosis in animal hosts [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/8\" class=\"abstract_t\">8</a>]. Infected animals excrete Brucellae in urine, milk, placenta, and the products of miscarriages. In this way, the bacteria are disseminated and infect other animals and humans [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/29\" class=\"abstract_t\">29</a>].</p><p>Bovine <em>B. melitensis</em> infection is emerging as an increasingly serious public health problem in some countries. A related problem has been observed in some South American countries, where <em>B. suis</em> biovar 1 has become established in cattle [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/17,21,33\" class=\"abstract_t\">17,21,33</a>].</p><p>Brucellosis vaccines for animal use (<em>B. abortus</em> B19 and RB51 for cattle; <em>B. melitensis </em>Rev 1 for small ruminants) are live attenuated vaccines [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/6,8,21,34\" class=\"abstract_t\">6,8,21,34</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-treatment-of-brucellosis#H19\" class=\"medical medical_review\">&quot;Clinical manifestations, diagnosis, and treatment of brucellosis&quot;, section on 'Prevention'</a>.)</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Human infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The prevalence of <em>Brucella</em> infection in humans depends upon several factors, including geography, husbandry practices, slaughtering, food preparation techniques, and trade [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/35\" class=\"abstract_t\">35</a>]. All age groups and both sexes are affected. Humans acquire the infection through the consumption of products from infected animals, such as unpasteurized milk, cheese, and insufficiently cooked or raw meat [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/36,37\" class=\"abstract_t\">36,37</a>]. Infection may also result from the entry of the bacteria from infected animals or their secretions through skin lesions, conjunctiva, or from inhalation of contaminated dust or aerosols [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/7,29\" class=\"abstract_t\">7,29</a>].</p><p>Family history of brucellosis in endemic regions varies from 9 to 51 percent; screening household members of an index case detects additional unrecognized cases, allowing early diagnosis and prevention of complications [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/33,37\" class=\"abstract_t\">33,37</a>].</p><p>In the United States, 100 to 200 cases of human brucellosis are reported annually, most of them due to <em>B. melitensis</em> [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/32\" class=\"abstract_t\">32</a>]. As an example, transmission of brucellosis occurred in association with consumption of unpasteurized milk from a dairy in Texas in 2017 [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/38-40\" class=\"abstract_t\">38-40</a>]. Imported unpasteurized dairy products, such as fresh goat or sheep cheese from neighboring countries (particularly Mexico), are an important source of infection in the United States [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/4,21,32,34\" class=\"abstract_t\">4,21,32,34</a>].</p><p>In Australia and the United States, <em>B. suis</em> has been observed in approximately 20 percent of feral swine, and infection among hunters has been described [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/41-43\" class=\"abstract_t\">41-43</a>].</p><p>Human-to-human transmission is unusual. Rare cases due to blood transfusion, tissue transplantation, breastfeeding, sexual contact, congenital, laboratory, and nosocomial infection have been reported [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/44-47\" class=\"abstract_t\">44-47</a>].</p><p>Brucellosis vaccines for animal use are live attenuated vaccines and are known to cause disease in humans during the process of preparation or by accidental inoculation [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/6,8,21,34\" class=\"abstract_t\">6,8,21,34</a>].</p><p class=\"headingAnchor\" id=\"H2042154\"><span class=\"h3\">Occupational exposure</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Laboratory workers handling <em>Brucella</em> cultures are at a high risk of acquiring brucellosis through accidents, aerosolization, <span class=\"nowrap\">and/or</span> inadequate laboratory precautions (<a href=\"image.htm?imageKey=ID%2F78971\" class=\"graphic graphic_table graphicRef78971 \">table 1</a>). Laboratory-associated infections represent 2 percent of reported cases [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/48\" class=\"abstract_t\">48</a>]. In one review of laboratory-associated infections, <em>Brucella</em> spp accounted for approximately 8 percent of all laboratory infections, 16 percent of bacterial infections, and 4 percent of deaths [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/49\" class=\"abstract_t\">49</a>]. Biosafety level 3 practices, containment equipment, and facilities are recommended for all manipulations of <em>Brucella</em> cultures, and laboratory workers should be informed in advance about the diagnostic possibility of brucellosis in order to implement appropriate diagnostic precautions [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/4,50\" class=\"abstract_t\">4,50</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-treatment-of-brucellosis#H22057110\" class=\"medical medical_review\">&quot;Clinical manifestations, diagnosis, and treatment of brucellosis&quot;, section on 'Postexposure prophylaxis'</a>.)</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Brucellae are readily ingested by polymorphonuclear cells and macrophages, which then pass to local lymph nodes (<a href=\"image.htm?imageKey=ID%2F77627\" class=\"graphic graphic_figure graphicRef77627 \">figure 1</a>) [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/6,51\" class=\"abstract_t\">6,51</a>]. Organisms replicate intracellularly, and bacteria from lysed cells can infect other cells or disseminate systemically [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/6\" class=\"abstract_t\">6</a>]. Some Brucellae are destroyed within the lysosomes of phagocytic cells, while others are capable of preventing phagosome-lysosome fusion and avoiding intracellular killing in lysosomes to reach an endoplasmic reticulum-derived vacuole [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/52,53\" class=\"abstract_t\">52,53</a>].</p><p>During the intracellular stage, Brucellae display a range of survival strategies to suppress host immune response and avoid immediate destruction; they circumvent strong activation of the innate immune system, withstand the direct action of complement and other bactericidal substances, and evade the action of polymorphonuclear cells and macrophages. <em>Brucella </em>establish long-lasting infection within host cells [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/51,52,54\" class=\"abstract_t\">51,52,54</a>]. All these activities may promote the chronicity of infection [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/55-57\" class=\"abstract_t\">55-57</a>].</p><p>No classical virulence factors, such as toxins, cytolysins, capsules, fimbria, flagella, plasmids, lysogenic phages, resistant forms, antigenic variation, endotoxic lipopolysaccharide (LPS), or apoptotic inducers, have been described in Brucellae [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/52,58\" class=\"abstract_t\">52,58</a>]. The smooth LPS and proteins involved in signaling, gene regulation, and transmembrane transportation are suspected to be involved in virulence. The LPS does not trigger a strong innate immune response, and, thus, the synthesis of inflammatory cytokines is low during the early stages of infection, which prevents a timely triggering of Th1 responses. Moreover, LPS has a role in cell entry and immune evasion of the infected cell and is essential for intracellular survival [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/59-61\" class=\"abstract_t\">59-61</a>]. In addition, the LPS in <em>Brucella </em>may be involved in the inhibition of apoptosis of infected cells, thus preventing host cell elimination [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/55,62\" class=\"abstract_t\">55,62</a>].</p><p>A regulatory two-component system (<em>Brucella</em> virulence-related regulator or sensor <span class=\"nowrap\">proteins-BvrR/BvrS)</span> controls the outer membrane composition and is involved in aspects of the pathogen metabolism after ingestion by phagocytic cells [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/63-65\" class=\"abstract_t\">63-65</a>]. <em>Brucella</em> possesses a type IV secretion system VirB and periplasmic cyclic beta-1,2-glucans, which enable the pathogen to reach its replicating niche in the endoplasmic reticulum [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/51,52,61,66\" class=\"abstract_t\">51,52,61,66</a>]. Once inside the endoplasmic reticulum, <em>Brucella </em>replicates extensively without restricting basic cellular functions or generating obvious cell damage [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/51,52\" class=\"abstract_t\">51,52</a>]. <em>Brucella</em> does not infect cells by intracellular spreading from cell to cell [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/52\" class=\"abstract_t\">52</a>].</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">The host response</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Antibody response in brucellosis plays a limited part in the overall host response [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/7\" class=\"abstract_t\">7</a>]. Cell-mediated immunity appears to be the principal mechanism of recovery as well as the mechanism for partial resistance to subsequent reinfection [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/29,67,68\" class=\"abstract_t\">29,67,68</a>]. The serum antibody response to <em>Brucella</em> infection in humans is characterized by an initial rise in antibody titers of the immunoglobulin (Ig)M class, followed in several weeks by a predominance of IgG antibodies. The IgG titers of agglutinins decline after successful treatment, although they may persist at high levels for months in cured patients [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/69-71\" class=\"abstract_t\">69-71</a>]. IgG and IgA titers may be increased in the setting of relapse [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/71\" class=\"abstract_t\">71</a>].</p><p>Control of brucellosis depends on activated macrophages and hence requires development of a Th1 type cell-mediated immune response involving interleukin (IL)-2, IL-12, interferon (IFN)-gamma, and tumor necrosis factor (TNF)-alpha [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/17,52\" class=\"abstract_t\">17,52</a>]. During infection, smooth LPS does not activate the complement pathway. In addition, impaired activity of natural killer cells and impaired macrophage generation of reactive oxygen intermediates, and interferon regulatory factors have been described [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/7\" class=\"abstract_t\">7</a>]. <em>Brucella</em> LPS is a poor inducer of IFN-gamma and TNF-alpha, both of which are essential for the elimination of the organism [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/72,73\" class=\"abstract_t\">72,73</a>]. IFN-gamma has a central role in the pathogenesis of brucellosis by activating macrophages, by inducing apoptosis, converting IgG to IgG2a, and increasing the expression of antigen-presenting molecules [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/7\" class=\"abstract_t\">7</a>]. In a study of patients with a polymorphism in the IFN-gamma gene, a significant increase in the IFN-gamma <span class=\"nowrap\">+874A/A</span> genotype was evident in the <em>Brucella</em>-infected group compared with controls, suggesting that those homozygous for the +874 allele may be relatively more susceptible to infection [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/74\" class=\"abstract_t\">74</a>]. TNF-alpha and IL-12 are essential to develop the Th1 type macrophage response leading to clearing of the organism [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/75,76\" class=\"abstract_t\">75,76</a>]. Gamma delta T cells, and predominantly the fraction of V gamma 9V delta 2 T cells, apparently continue to function and aid survival of the host [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/55,77\" class=\"abstract_t\">55,77</a>].</p><p>In summary, the immune response in brucellosis can be classified into three mechanisms. First, IFN-gamma activates the bactericidal function in macrophages to hamper the intracellular survival of <em>Brucella</em>. Then, cytotoxicity of CD8+ and gamma delta T cells destroys the infected macrophages. Finally, Th1-type antibodies opsonize the pathogen to facilitate phagocytosis [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/56\" class=\"abstract_t\">56</a>].</p><p class=\"headingAnchor\" id=\"H266929977\"><span class=\"h2\">Histology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In humans, <em>Brucella</em> spp infection results in the formation of noncaseating sarcoidosis-like granulomas, consisting of epithelioid cells, polymorphonuclear leukocytes, lymphocytes, and some giant cells. The granulomatous response is characteristic of <em>B. abortus</em> infection. In <em>B. melitensis</em> infection, the granulomata are very small. <em>B. suis</em> infection is often accompanied by chronic abscess formation [<a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/29,68\" class=\"abstract_t\">29,68</a>].</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Brucellosis is a zoonotic infection transmitted to humans by contact with fluids from infected animals (sheep, cattle, goats, pigs, or other animals) or derived food products such as unpasteurized milk and cheese. <em>B. melitensis</em> is the species that causes most of the infections in humans. <em>B. abortus</em>, <em>B. suis</em>, and <em>B. canis </em>also have potential to cause human infections. (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above and <a href=\"#H2037820\" class=\"local\">'Taxonomy'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>Brucella </em>spp are small gram-negative aerobic coccobacilli lacking a capsule. The organisms require complex media and conditions for growth. <em>Brucella </em>organisms can survive for weeks in the environment. They are sensitive to heat, most commonly used disinfectants, and pasteurization. (See <a href=\"#H2\" class=\"local\">'Microbiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Brucellosis occurs worldwide; major endemic areas include countries of the Mediterranean basin, Persian Gulf, the Indian subcontinent, and parts of Mexico and Central and South America. Domestic animal hosts can harbor a variety of different <em>Brucella </em>species: <em>B. abortus </em>in cattle, <em>B. melitensis</em> in sheep, goats, and camels, and <em>B. suis</em> in swine. (See <a href=\"#H3\" class=\"local\">'Epidemiology'</a> above and <a href=\"#H2037820\" class=\"local\">'Taxonomy'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Humans can acquire brucellosis via direct inoculation through cuts and skin abrasions, direct conjunctival inoculation, inhalation of infectious aerosols, or ingestion of contaminated food. (See <a href=\"#H5\" class=\"local\">'Human infection'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Brucellosis is among the most commonly reported laboratory-acquired bacterial infections. Laboratory workers handling <em>Brucella</em> cultures are at high risk of acquiring brucellosis through accidents, aerosolization, <span class=\"nowrap\">and/or</span> inadequate laboratory precautions. Biosafety level 3 practices are recommended for all manipulations of <em>Brucella</em> cultures, and laboratory workers should be informed in advance about the diagnostic possibility of brucellosis in order to implement appropriate diagnostic precautions (<a href=\"image.htm?imageKey=ID%2F78971\" class=\"graphic graphic_table graphicRef78971 \">table 1</a>). (See <a href=\"#H2042154\" class=\"local\">'Occupational exposure'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Lipopolysaccharide has a role in cell entry and immune evasion of the infected cell and is essential for intracellular survival. <em>Brucella</em> spp invade and persist in the host via inhibition of programmed cell death. Replication of the bacterium takes place in the endoplasmic reticulum. (See <a href=\"#H7\" class=\"local\">'Pathogenesis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The human host response is both humoral and T cell mediated. Cell-mediated immunity appears to be the principal mechanism of recovery. Antibodies are important for diagnostic purposes but appear to play a minor role in the immune response to infection. (See <a href=\"#H7\" class=\"local\">'Pathogenesis'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/1\" class=\"nounderline abstract_t\">Bosilkovski M, Dimzova M, Grozdanovski K. Natural history of brucellosis in an endemic region in different time periods. Acta Clin Croat 2009; 48:41.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/2\" class=\"nounderline abstract_t\">Colmenero JD, Reguera JM, Martos F, et al. Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine (Baltimore) 1996; 75:195.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/3\" class=\"nounderline abstract_t\">Greenfield RA, Drevets DA, Machado LJ, et al. Bacterial pathogens as biological weapons and agents of bioterrorism. Am J Med Sci 2002; 323:299.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/4\" class=\"nounderline abstract_t\">Pappas G, Panagopoulou P, Christou L, Akritidis N. Brucella as a biological weapon. Cell Mol Life Sci 2006; 63:2229.</a></li><li class=\"breakAll\">Alton GG, Jones LM, Angus RD, Verger JM. Techniques for the brucellosis laboratory, Institut National de la recherche Agronomique, Paris 1988.</li><li class=\"breakAll\">Wright SG. Brucellosis. In: Hunter&rsquo;s Tropical Medicine and Emerging Infectious Diseases, 8th ed, Strickland GT (Ed), W.B. Saunders Company, Philadelphia 2000. p.416.</li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/7\" class=\"nounderline abstract_t\">Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med 2005; 352:2325.</a></li><li class=\"breakAll\">WHO/CDS/EPR/2006.7. Brucellosis in humans and animals Geneva: World Health Organization, 2006.</li><li class=\"breakAll\">Lindquist D, Chu MC, Probert WWS. Francisella and Brucella. In: Manual of Clinical Microbiology, 9th ed, Murray PR, Baron EJO, Jorgensen JH, et al (Eds), ASM Press, Washington, DC 2007. p.824.</li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/10\" class=\"nounderline abstract_t\">Sohn AH, Probert WS, Glaser CA, et al. Human neurobrucellosis with intracerebral granuloma caused by a marine mammal Brucella spp. Emerg Infect Dis 2003; 9:485.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/11\" class=\"nounderline abstract_t\">McDonald WL, Jamaludin R, Mackereth G, et al. Characterization of a Brucella sp. strain as a marine-mammal type despite isolation from a patient with spinal osteomyelitis in New Zealand. J Clin Microbiol 2006; 44:4363.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/12\" class=\"nounderline abstract_t\">Centers for Disease Control and Prevention (CDC). Human exposures to marine Brucella isolated from a harbor porpoise - Maine, 2012. MMWR Morb Mortal Wkly Rep 2012; 61:461.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/13\" class=\"nounderline abstract_t\">Jahans KL, Foster G, Broughton ES. The characterisation of Brucella strains isolated from marine mammals. Vet Microbiol 1997; 57:373.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/14\" class=\"nounderline abstract_t\">Pappas G. The changing Brucella ecology: novel reservoirs, new threats. Int J Antimicrob Agents 2010; 36 Suppl 1:S8.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/15\" class=\"nounderline abstract_t\">Al Dahouk S, N&ouml;ckler K. Implications of laboratory diagnosis on brucellosis therapy. Expert Rev Anti Infect Ther 2011; 9:833.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/16\" class=\"nounderline abstract_t\">Whatmore AM, Davison N, Cloeckaert A, et al. Brucella papionis sp. nov., isolated from baboons (Papio spp.). Int J Syst Evol Microbiol 2014; 64:4120.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/17\" class=\"nounderline abstract_t\">Corbel MJ. Brucellosis: an overview. Emerg Infect Dis 1997; 3:213.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/18\" class=\"nounderline abstract_t\">Halling SM, Peterson-Burch BD, Bricker BJ, et al. Completion of the genome sequence of Brucella abortus and comparison to the highly similar genomes of Brucella melitensis and Brucella suis. J Bacteriol 2005; 187:2715.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/19\" class=\"nounderline abstract_t\">DelVecchio VG, Kapatral V, Redkar RJ, et al. The genome sequence of the facultative intracellular pathogen Brucella melitensis. Proc Natl Acad Sci U S A 2002; 99:443.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/20\" class=\"nounderline abstract_t\">Paulsen IT, Seshadri R, Nelson KE, et al. The Brucella suis genome reveals fundamental similarities between animal and plant pathogens and symbionts. Proc Natl Acad Sci U S A 2002; 99:13148.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/21\" class=\"nounderline abstract_t\">Godfroid J, Cloeckaert A, Liautard JP, et al. From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis. Vet Res 2005; 36:313.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/22\" class=\"nounderline abstract_t\">Bricker BJ, Ewalt DR, MacMillan AP, et al. Molecular characterization of Brucella strains isolated from marine mammals. J Clin Microbiol 2000; 38:1258.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/23\" class=\"nounderline abstract_t\">G&aacute;ndara B, Merino AL, Rogel MA, Mart&iacute;nez-Romero E. Limited genetic diversity of Brucella spp. J Clin Microbiol 2001; 39:235.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/24\" class=\"nounderline abstract_t\">Verger JM, Grimont F, Grimont PAD, Grayon M. Brucella: A monospecific genus shown by deoxyribonucleic acid hybridization. Int J Syst Bacteriol 1985; 35:292.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/25\" class=\"nounderline abstract_t\">Moreno E, Cloeckaert A, Moriy&oacute;n I. Brucella evolution and taxonomy. Vet Microbiol 2002; 90:209.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/26\" class=\"nounderline abstract_t\">Chain PS, Comerci DJ, Tolmasky ME, et al. Whole-genome analyses of speciation events in pathogenic Brucellae. Infect Immun 2005; 73:8353.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/27\" class=\"nounderline abstract_t\">Scholz HC, Hubalek Z, Sedl&aacute;cek I, et al. Brucella microti sp. nov., isolated from the common vole Microtus arvalis. Int J Syst Evol Microbiol 2008; 58:375.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/28\" class=\"nounderline abstract_t\">Al Dahouk S, N&ouml;ckler K, Tomaso H, et al. Seroprevalence of brucellosis, tularemia, and yersiniosis in wild boars (Sus scrofa) from north-eastern Germany. J Vet Med B Infect Dis Vet Public Health 2005; 52:444.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/29\" class=\"nounderline abstract_t\">Doganay M, Aygen B. Human brucellosis: An overview. Int J Infect Dis 2003; 7:173.</a></li><li class=\"breakAll\">Corbel MJ. Overview. In: Brucellosis, Madkuor MM (Ed), Butterworths, University Press, Cambridge (UK) 1989. p.71.</li><li class=\"breakAll\">Corbel MJ. Microbiology of the genus Brucella. In: Brucellosis: Clinical and Laboratory Aspects, Young EJ, Corbel MJ (Eds), CRC Press, Boca Raton 1989. p.53.</li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/32\" class=\"nounderline abstract_t\">Pappas G, Papadimitriou P, Akritidis N, et al. The new global map of human brucellosis. Lancet Infect Dis 2006; 6:91.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/33\" class=\"nounderline abstract_t\">Mantur BG, Amarnath SK, Shinde RS. Review of clinical and laboratory features of human brucellosis. Indian J Med Microbiol 2007; 25:188.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/34\" class=\"nounderline abstract_t\">Young EJ. Brucellosis: current epidemiology, diagnosis, and management. Curr Clin Top Infect Dis 1995; 15:115.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/35\" class=\"nounderline abstract_t\">Bosilkovski M, Krteva L, Caparoska S, Dimzova M. Osteoarticular involvement in brucellosis: study of 196 cases in the Republic of Macedonia. Croat Med J 2004; 45:727.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/36\" class=\"nounderline abstract_t\">Bosilkovski M, Krteva L, Dimzova M, Kondova I. Brucellosis in 418 patients from the Balkan Peninsula: exposure-related differences in clinical manifestations, laboratory test results, and therapy outcome. Int J Infect Dis 2007; 11:342.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/37\" class=\"nounderline abstract_t\">Bosilkovski M, Krteva L, Dimzova M, et al. Human brucellosis in Macedonia - 10 years of clinical experience in endemic region. Croat Med J 2010; 51:327.</a></li><li class=\"breakAll\">Centers for Disease Control and Prevention. CDC and Texas Health Officials Warn About Illness Linked to Raw Milk from Texas Dairy, September 17, 2017. https://www.cdc.gov/media/releases/2017/p0915-raw-milk-brucella.html (Accessed on September 18, 2017).</li><li class=\"breakAll\">Centers for Disease Control and Prevention. Exposure to RB51 through Raw Milk or Milk Products: How to Reduce Risk of Infection. https://www.cdc.gov/brucellosis/clinicians/rb51-raw-milk.html (Accessed on September 18, 2017).</li><li class=\"breakAll\">Centers for Disease Control and Prevention. People in Four States May Be Drinking Contaminated Raw Milk, November 21, 2017. http://www.cdc.gov/media/releases/2017/p1121-contaminated-raw-milk.html (Accessed on November 28, 2017).</li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/41\" class=\"nounderline abstract_t\">Eales KM, Norton RE, Ketheesan N. Brucellosis in northern Australia. Am J Trop Med Hyg 2010; 83:876.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/42\" class=\"nounderline abstract_t\">Robson JM, Harrison MW, Wood RN, et al. Brucellosis: re-emergence and changing epidemiology in Queensland. Med J Aust 1993; 159:153.</a></li><li class=\"breakAll\">Salvana EMT, Salata RA. Brucellosis. In: Goldman-Cecil Medicine, 25th ed, Goldman L, Schafer AI (Eds), Elsevier, Philadelphia 2015. p.1979.</li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/44\" class=\"nounderline abstract_t\">Poulou A, Markou F, Xipolitos I, Skandalakis PN. A rare case of Brucella melitensis infection in an obstetrician during the delivery of a transplacentally infected infant. J Infect 2006; 53:e39.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/45\" class=\"nounderline abstract_t\">Mesner O, Riesenberg K, Biliar N, et al. The many faces of human-to-human transmission of brucellosis: congenital infection and outbreak of nosocomial disease related to an unrecognized clinical case. Clin Infect Dis 2007; 45:e135.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/46\" class=\"nounderline abstract_t\">Mantur BG, Mangalgi SS, Mulimani M. Brucella melitensis--a sexually transmissible agent? Lancet 1996; 347:1763.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/47\" class=\"nounderline abstract_t\">Wang W, Liao Q, Wu X, et al. Potential risk of blood transfusion-transmitted brucellosis in an endemic area of China. Transfusion 2015; 55:586.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/48\" class=\"nounderline abstract_t\">Fiori PL, Mastrandrea S, Rappelli P, Cappuccinelli P. Brucella abortus infection acquired in microbiology laboratories. J Clin Microbiol 2000; 38:2005.</a></li><li class=\"breakAll\">Harding AL, Byers KB. Epidemiology of laboratory-associated infections. In: Biological safety: principles and practices (Third edition), Fleming DO, Hunt DL (Eds), ASM Press, Washington, DC 2000. p.35.</li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/50\" class=\"nounderline abstract_t\">Gruner E, Bernasconi E, Galeazzi RL, et al. Brucellosis: an occupational hazard for medical laboratory personnel. Report of five cases. Infection 1994; 22:33.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/51\" class=\"nounderline abstract_t\">Barquero-Calvo E, Chaves-Olarte E, Weiss DS, et al. Brucella abortus uses a stealthy strategy to avoid activation of the innate immune system during the onset of infection. PLoS One 2007; 2:e631.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/52\" class=\"nounderline abstract_t\">Gorvel JP, Moreno E. Brucella intracellular life: from invasion to intracellular replication. Vet Microbiol 2002; 90:281.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/53\" class=\"nounderline abstract_t\">Pizarro-Cerd&aacute; J, Moreno E, Gorvel JP. Invasion and intracellular trafficking of Brucella abortus in nonphagocytic cells. Microbes Infect 2000; 2:829.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/54\" class=\"nounderline abstract_t\">Delrue RM, Lestrate P, Tibor A, et al. Brucella pathogenesis, genes identified from random large-scale screens. FEMS Microbiol Lett 2004; 231:1.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/55\" class=\"nounderline abstract_t\">Dornand J, Gross A, Lafont V, et al. The innate immune response against Brucella in humans. Vet Microbiol 2002; 90:383.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/56\" class=\"nounderline abstract_t\">Ko J, Splitter GA. Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin Microbiol Rev 2003; 16:65.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/57\" class=\"nounderline abstract_t\">Skendros P, Sarantopoulos A, Tselios K, Boura P. Chronic brucellosis patients retain low frequency of CD4+ T-lymphocytes expressing CD25 and CD28 after Escherichia coli LPS stimulation of PHA-cultured PBMCs. Clin Dev Immunol 2008; 2008:327346.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/58\" class=\"nounderline abstract_t\">Moreno E, Moriyon I. Brucella melitensis: a nasty bug with hidden credentials for virulence. Proc Natl Acad Sci U S A 2002; 99:1.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/59\" class=\"nounderline abstract_t\">DelVecchio VG, Kapatral V, Elzer P, et al. The genome of Brucella melitensis. Vet Microbiol 2002; 90:587.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/60\" class=\"nounderline abstract_t\">Lapaque N, Moriyon I, Moreno E, Gorvel JP. Brucella lipopolysaccharide acts as a virulence factor. Curr Opin Microbiol 2005; 8:60.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/61\" class=\"nounderline abstract_t\">Boschiroli ML, Ouahrani-Bettache S, Foulongne V, et al. Type IV secretion and Brucella virulence. Vet Microbiol 2002; 90:341.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/62\" class=\"nounderline abstract_t\">Gross A, Terraza A, Ouahrani-Bettache S, et al. In vitro Brucella suis infection prevents the programmed cell death of human monocytic cells. Infect Immun 2000; 68:342.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/63\" class=\"nounderline abstract_t\">Guzman-Verri C, Manterola L, Sola-Landa A, et al. The two-component system BvrR/BvrS essential for Brucella abortus virulence regulates the expression of outer membrane proteins with counterparts in members of the Rhizobiaceae. Proc Natl Acad Sci U S A 2002; 99:12375.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/64\" class=\"nounderline abstract_t\">L&oacute;pez-Go&ntilde;i I, Guzm&aacute;n-Verri C, Manterola L, et al. Regulation of Brucella virulence by the two-component system BvrR/BvrS. Vet Microbiol 2002; 90:329.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/65\" class=\"nounderline abstract_t\">Manterola L, Moriy&oacute;n I, Moreno E, et al. The lipopolysaccharide of Brucella abortus BvrS/BvrR mutants contains lipid A modifications and has higher affinity for bactericidal cationic peptides. J Bacteriol 2005; 187:5631.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/66\" class=\"nounderline abstract_t\">Arenas GN, Staskevich AS, Aballay A, Mayorga LS. Intracellular trafficking of Brucella abortus in J774 macrophages. Infect Immun 2000; 68:4255.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/67\" class=\"nounderline abstract_t\">Skendros P, Pappas G, Boura P. Cell-mediated immunity in human brucellosis. Microbes Infect 2011; 13:134.</a></li><li class=\"breakAll\">Gotuzzo E, Pappas G. Brucellosis. In: Tropical Infectious Diseases: Principles, Pathogens and Practice, 3rd ed, Guerrant RL, Walker DH, Weller PF (Eds), Saunders Elsevier, Philadelphia 2011. p.271.</li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/69\" class=\"nounderline abstract_t\">Gazapo E, Gonzalez Lahoz J, Subiza JL, et al. Changes in IgM and IgG antibody concentrations in brucellosis over time: importance for diagnosis and follow-up. J Infect Dis 1989; 159:219.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/70\" class=\"nounderline abstract_t\">Ariza J, Pellicer T, Pallar&eacute;s R, et al. Specific antibody profile in human brucellosis. Clin Infect Dis 1992; 14:131.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/71\" class=\"nounderline abstract_t\">Al Dahouk S, Tomaso H, N&ouml;ckler K, et al. Laboratory-based diagnosis of brucellosis--a review of the literature. Part II: serological tests for brucellosis. Clin Lab 2003; 49:577.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/72\" class=\"nounderline abstract_t\">Zhan Y, Cheers C. Endogenous interleukin-12 is involved in resistance to Brucella abortus infection. Infect Immun 1995; 63:1387.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/73\" class=\"nounderline abstract_t\">Caron E, Liautard JP, K&ouml;hler S. Differentiated U937 cells exhibit increased bactericidal activity upon LPS activation and discriminate between virulent and avirulent Listeria and Brucella species. J Leukoc Biol 1994; 56:174.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/74\" class=\"nounderline abstract_t\">Bravo MJ, de Dios Colmenero J, Alonso A, Caballero A. Polymorphisms of the interferon gamma and interleukin 10 genes in human brucellosis. Eur J Immunogenet 2003; 30:433.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/75\" class=\"nounderline abstract_t\">Zhan Y, Liu Z, Cheers C. Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms. Infect Immun 1996; 64:2782.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/76\" class=\"nounderline abstract_t\">Zhan Y, Cheers C. Control of IL-12 and IFN-gamma production in response to live or dead bacteria by TNF and other factors. J Immunol 1998; 161:1447.</a></li><li><a href=\"https://www.uptodate.com/contents/microbiology-epidemiology-and-pathogenesis-of-brucella/abstract/77\" class=\"nounderline abstract_t\">Oliaro J, Dudal S, Liautard J, et al. Vgamma9Vdelta2 T cells use a combination of mechanisms to limit the spread of the pathogenic bacteria Brucella. J Leukoc Biol 2005; 77:652.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 3147 Version 17.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H9\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2037820\" id=\"outline-link-H2037820\">TAXONOMY</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">MICROBIOLOGY</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">EPIDEMIOLOGY</a><ul><li><a href=\"#H4\" id=\"outline-link-H4\">Animal infection</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">Human infection</a><ul><li><a href=\"#H2042154\" id=\"outline-link-H2042154\">- Occupational exposure</a></li></ul></li></ul></li><li><a href=\"#H7\" id=\"outline-link-H7\">PATHOGENESIS</a><ul><li><a href=\"#H8\" id=\"outline-link-H8\">The host response</a></li><li><a href=\"#H266929977\" id=\"outline-link-H266929977\">Histology</a></li></ul></li><li><a href=\"#H9\" id=\"outline-link-H9\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ID/3147|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=ID/77627\" class=\"graphic graphic_figure\">- Pathogenesis of Brucella</a></li></ul></li><li><div id=\"ID/3147|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=ID/78971\" class=\"graphic graphic_table\">- Lab practices to avoid Brucella exposure</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-treatment-of-brucellosis\" class=\"medical medical_review\">Clinical manifestations, diagnosis, and treatment of brucellosis</a></li></ul></div></div>","javascript":null}